Product NDC: | 59676-310 |
Proprietary Name: | PROCRIT |
Non Proprietary Name: | Erythropoietin |
Active Ingredient(s): | 10000 [iU]/mL & nbsp; Erythropoietin |
Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59676-310 |
Labeler Name: | Janssen Products, LP |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103234 |
Marketing Category: | BLA |
Start Marketing Date: | 19890601 |
Package NDC: | 59676-310-02 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 CARTON (59676-310-02) > 1 mL in 1 VIAL, SINGLE-DOSE (59676-310-00) |
NDC Code | 59676-310-02 |
Proprietary Name | PROCRIT |
Package Description | 25 VIAL, SINGLE-DOSE in 1 CARTON (59676-310-02) > 1 mL in 1 VIAL, SINGLE-DOSE (59676-310-00) |
Product NDC | 59676-310 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Erythropoietin |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 19890601 |
Marketing Category Name | BLA |
Labeler Name | Janssen Products, LP |
Substance Name | ERYTHROPOIETIN |
Strength Number | 10000 |
Strength Unit | [iU]/mL |
Pharmaceutical Classes | Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE] |